Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

REMIFENTANIL FOR INJECTION

TEVA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is REMIFENTANIL FOR INJECTION discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that REMIFENTANIL FOR INJECTION 2MG has been permanently discontinued (last updated January 24, 2020). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is REMIFENTANIL FOR INJECTION not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file3 products
Affected strength2MG
Last updated2020-01-24

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

ULTIVA

ABBVIE CORPORATION

2MG · DIN 02230410

Same strengthSame dosage formSame routeNo current shortage

Other Products

REMIFENTANIL HYDROCHLORIDE FOR INJECTION

STERIMAX INC

1MG · DIN 02366460

Different strengthSame dosage formSame routeNo current shortage

REMIFENTANIL FOR INJECTION

SANDOZ CANADA INCORPORATED

1MG · DIN 02393204

Different strengthSame dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

DIN

02344432

Strength

2MG

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS

Active Ingredient

REMIFENTANIL

See all REMIFENTANIL products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History